Concepedia

Publication | Open Access

Phase II studies of nebulised Arikace in CF patients with<i>Pseudomonas aeruginosa</i>infection

DOIFull Paper Access

218

Citations

24

References

2013

Year

John P. Clancy, Lieven Dupont, Michael W. Konstan, Joanne Billings, S. Fustik, Christopher H. Goss, James Lymp, Predrag Minić, Alexandra L. Quittner, Ronald C. Rubenstein,
Thorax

Abstract

Once-daily Arikace demonstrated acute tolerability, safety, biologic activity and efficacy in patients with CF with P aeruginosa infection.

References

YearCitations

Page 1